EIF2A and breast cancer: For instance, increased oncogenic transformation has been evidenced in fibroblasts after inhibiting the PERK target eIF2α [62], and increased proliferation and mammary tumor formation has been reported upon expression of a dominant-negative form of PERK in mammary epithelial cells [63].